Skip to main content
25 January 2021
Last updated:
Monday 25 January 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

New chief medical officer and VP manufacturing for AM-Pharma

Monday 9 November 2020
Company
AM-Pharma BV
Appointee Name
Maarten Kraan and  
Teun van de Laar
Country

Netherlands

AM-Pharma BV has named Maarten Kraan as chief medical officer and Teun van de Laar as head of manufacturing and supply chain management. The company, based in the Netherlands, is focused on the treatment of kidney disease, sepsis and organ injury and has appointed the pair to support a global pivotal trial in sepsis-associated acute kidney injury. Dr Kraan joins the company from Pierre Fabre SA, where he was the head of research & development. He has also worked at Stallergenes Greer Ltd, Therachon AG, and AstraZeneca Plc, among others, and holds a MD and PhD in immunology from Leiden University. Dr van de Laar was most recently head of CMC and technical operations at Aduro Biotech BV. He holds an MSc in bioprocess technology from Wageningen University and a PhD in cell biology from Utrecht University.
The appointments were announced on 20 October 2020.

Copyright 2020 Evernow Publishing Ltd

 

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

T-knife appoints Thomas Soloway as chief executive
Thursday January 21 2021
Domainex makes two executive appointments
Thursday January 21 2021
Richard Francis named CEO of Purespring
Tuesday January 19 2021
Klaas Zuideveld becomes CEO of Versameb
Saturday January 16 2021
MorphoSys appoints new CFO
Thursday January 7 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.